We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
3M
MMM
$94.3B
| $84.8M | 0.19% |
461,776
+457,470
| +10,624% | +$90.6M |
|
127
Aptiv
APTV
$10.3B
| $83.9M | 0.19% |
987,832
+214,546
| +28% | +$19.5M |
|
128
American International
AIG
$41.3B
| $82.8M | 0.19% |
+1,521,152
| New | +$89.9M |
|
|
SPLK
129
DELISTED
Splunk Inc
SPLK
| $81.6M | 0.19% |
+829,152
| New | +$79.1M |
|
130
POSCO
PKX
$17.5B
| $81.6M | 0.19% |
1,034,529
-178,965
| -15% | -$15.1M |
|
|
WBA
131
DELISTED
Walgreens Boots Alliance
WBA
| $80.3M | 0.18% |
1,226,184
-4,665,661
| -79% | -$333M |
|
132
Diageo
DEO
$53.6B
| $79.7M | 0.18% |
588,549
-605,322
| -51% | -$84.2M |
|
133
Xylem
XYL
$28.1B
| $79.6M | 0.18% |
1,034,845
+863,899
| +505% | +$63.9M |
|
134
Marriott International
MAR
$92.3B
| $78.5M | 0.18% |
+577,118
| New | +$80.9M |
|
|
BBL
135
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $77.3M | 0.18% |
1,944,883
+247,444
| +15% | +$10.4M |
|
136
TE Connectivity
TEL
$62.6B
| $75.6M | 0.17% |
756,469
+750,069
| +11,720% | +$75.8M |
|
137
Credicorp
BAP
$30.7B
| $75.4M | 0.17% |
332,092
+325,607
| +5,021% | +$72.3M |
|
138
Synchrony
SYF
$25.6B
| $75.3M | 0.17% |
2,247,200
+2,106,200
| +1,494% | +$78.2M |
|
139
Alphabet (Google) Class A
GOOGL
$4.33T
| $74.7M | 0.17% |
1,440,000
+975,480
| +210% | +$54.1M |
|
140
Prudential Financial
PRU
$41.8B
| $74.7M | 0.17% |
721,114
-875,424
| -55% | -$98.7M |
|
141
Trimble
TRMB
$13.9B
| $74.7M | 0.17% |
2,080,711
+107,359
| +5% | +$4.33M |
|
142
Agilent Technologies
A
$41.2B
| $72M | 0.17% |
1,076,235
-650,694
| -38% | -$45.6M |
|
143
Alibaba
BABA
$308B
| $72M | 0.17% |
392,275
-481,978
| -55% | -$90.8M |
|
144
L3Harris
LHX
$53.4B
| $71.8M | 0.16% |
+445,355
| New | +$68M |
|
145
Manulife Financial
MFC
$73.5B
| $71.5M | 0.16% |
3,848,200
+3,818,600
| +12,901% | +$76.4M |
|
146
Exelon
EXC
$47B
| $71M | 0.16% |
2,550,883
+1,591,214
| +166% | +$43M |
|
147
Intel
INTC
$513B
| $69M | 0.16% |
1,324,388
+1,286,678
| +3,412% | +$61.1M |
|
148
Signet Jewelers
SIG
$3.76B
| $68.8M | 0.16% |
1,786,467
+1,258,212
| +238% | +$62.5M |
|
149
Genpact
G
$5.76B
| $68.5M | 0.16% |
2,141,713
+649,094
| +43% | +$21.1M |
|
150
Amphenol
APH
$209B
| $68.1M | 0.16% |
3,163,268
+2,227,984
| +238% | +$50.2M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.